Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier
- 1 December 2018
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 142 (6), 1710-1718
- https://doi.org/10.1016/j.jaci.2018.10.015
Abstract
No abstract availableKeywords
Funding Information
- Leukemia and Lymphoma Society
- Swiss National Science Foundation
This publication has 109 references indexed in Scilit:
- Foxp3+ T Cells Induce Perforin-Dependent Dendritic Cell Death in Tumor-Draining Lymph NodesImmunity, 2010
- Chromogranin A is an autoantigen in type 1 diabetesNature Immunology, 2010
- Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupusProceedings of the National Academy of Sciences of the United States of America, 2009
- Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parametersNature Medicine, 2009
- The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammationNature Immunology, 2009
- Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responsesNature, 2009
- Suppressive Efficacy and Proliferative Capacity of Human Regulatory T Cells in Allogeneic and Xenogeneic ResponsesTransplantation, 2008
- Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cellsin vitroand actively inhibit their maturationProceedings of the National Academy of Sciences of the United States of America, 2008
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune DestructionImmunity, 2008
- The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthmaClinical and Experimental Immunology, 2007